Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 14 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

36%

5 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

Phase 4
5(55.6%)
N/A
4(44.4%)
9Total
Phase 4(5)
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (14)

Showing 14 of 14 trials
NCT07358299Phase 4Not Yet Recruiting

Haemodynamic Effects and Complications of Continuous Versus Single-shot Spinal Anaesthesia for HIP Fracture Surgery

Role: collaborator

NCT06289790Not ApplicableCompleted

Erector Spinae Plane (ESP) Block vs Intravenous Lignocaine Infusion in (VATS)

Role: lead

NCT06860854Not Yet Recruiting

EPidural's Impact on Contractions and Fetal REsponse

Role: lead

NCT06403982Not ApplicableEnrolling By Invitation

The Influence of Oxytocin on Intrapartum Fetal Well-being and Delivery Outcomes in Patients Receiving Epidural Analgesia

Role: lead

NCT06030661Unknown

The HF-POL Study - Multicenter Study of Polish Patients With HF and LVEF >40%

Role: collaborator

NCT04695106Phase 4Recruiting

Dual Antithrombotic Therapy With Dabigatran and Ticagrelor in Patients With ACS and Non-valvular AF Undergoing PCI

Role: collaborator

NCT02996552Not ApplicableRecruiting

Annuloplasty for Not-Severe TR in Patients Undergoing MV Repair Versus Mitral Repair Only (NOSTRUM)

Role: collaborator

NCT04377412Unknown

Risk Factors for Anxiety and Depression Among Pregnant Women During the COVID-19 Pandemic

Role: collaborator

NCT04321473Unknown

Registry on Left Main Coronary Artery Bifurcation Percutaneous Intervention

Role: collaborator

NCT03838341Unknown

Stand-alone Totally Thoracoscopic Left Atrial Appendage Occlusion Using AtriClip® Device in Non-valvular Atrial Fibrillation.

Role: lead

NCT03548272Phase 4Unknown

BiOSS LIM C vs 2nd Generation DES in Non-LM Bifurcations

Role: lead

NCT02545985Not ApplicableCompleted

First-in-man Sirolimus-eluting Prolim® Stent Registry

Role: lead

NCT02198300Phase 4Completed

DES Versus BiOSS LIM - POLBOS II Study

Role: lead

NCT02192840Phase 4Completed

POLish Bifurcation Optimal Stenting Study

Role: lead

All 14 trials loaded